Press Releases

The Department of Pathology at Cooper University Health Care has added the Genexus Integrated Sequencer, a new, fully automated, next-generation rapid gene sequencing technology to its diagnostic resources. Gene sequencing allows physicians and scientists to identify and understand the genetic profiles of many viruses, tumors, and other specimens.

Cooper is one of a very few health systems in New Jersey that is able to perform next generation gene sequencing on site. Read more.

Cooper University Health Care’s Critical Care team will receive two national awards from the Society of Critical Care Medicine (SCCM) for their outstanding efforts during the COVID-19 pandemic. The two awards – The Family-Centered Care Innovation Award and the 2022 ICU Heroes Award – will be presented at the 51^st SCCM Critical Care Congress in February.

“Our critical care team has performed with courage and distinction throughout the pandemic and these two prestigious awards are well deserved recognition of their expertise and commitment to serving patients throughout the region,” said Kevin O’Dowd, JD, co-CEO of Cooper. Read more.

In recognition of Boost NJ Day, a statewide effort to get as many New Jersey residents vaccinated against COVID-19 before Christmas and the New Year holidays, Cooper University Health Care reminds the community of the availability of vaccinations for all citizens ages 5 and up at more than 40 of its conveniently located primary care offices throughout South Jersey.

“As we enter the winter months, we encourage people not to take a chance with COVID-19 variants and make sure to get their first, second, or booster vaccine dose. Read more.

Cooper University Health Care pediatric emergency room physician, Jonathan Reisman, MD, ponders life, culture and the natural world through the lens of anatomy and medicine in a recently published book, The Unseen Body: A Doctor’s Journey Through the Hidden Wonders of Human Anatomy.

As a physician, adventure traveler, and naturalist, Dr. Reisman share new perspectives on the body through personal experiences and travels to exotic locations such as the Arctic region and the Himalayas among others. Read more.

The Cardiac Partners at Cooper and Inspira team recently became the first in the Northeast Region to implant Abbott’s Amplatzer Amulet left atrial appendage (LAA) occluder, a new device recently approved by the FDA to treat patients with atrial fibrillation (AFib) who are also at risk of ischemic stroke.

George E. Mark, MD, FACC, successfully implanted the Amulet device in a male patient in October as part of a multidisciplinary team led by Sajjad A. Read more.